TP53 and neoplasm: EZH2 inhibition can suppress tumorigenic behaviours by reducing cell proliferation and invasion, inducing autophagy and apoptosis, and causing G1 phase arrest accompanied by increased expression of tumour suppressors such as p16, p53, and p21 [22,30,31,32,33,34].